---
document_datetime: 2023-09-21 20:29:16
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lydisilka-epar-all-authorised-presentations_en.pdf
document_name: lydisilka-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.9849224
conversion_datetime: 2025-12-18 10:16:09.3724
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength       | Pharmaceutical Form   | Route of Administration   | Immediate Packaging   | Pack size   |
|------------------|-------------------|----------------|-----------------------|---------------------------|-----------------------|-------------|
| EU/1/21/1548/001 | Lydisilka         | 3 mg / 14.2 mg | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 28 tablets  |
| EU/1/21/1548/002 | Lydisilka         | 3 mg / 14.2 mg | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 84 tablets  |
| EU/1/21/1548/003 | Lydisilka         | 3 mg / 14.2 mg | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 168 tablets |
| EU/1/21/1548/004 | Lydisilka         | 3 mg / 14.2 mg | Film-coated tablet    | Oral use                  | blister (PVC/alu)     | 364 tablets |